Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related Genes

18 Mar 2021

Abstract excerpt

OBJECTIVE: To screen lung adenocarcinoma (LUAC)-specific cell-cycle-related genes (CCRGs) and develop a prognostic signature for patients with LUAC. METHODS: The GSE68465, GSE42127, and GSE30219 data sets were downloaded from the GEO database. Single-sample gene set enrichment analysis was used to calculate the cell cycle enrichment of each sample in GSE68465 to identify CCRGs in LUAC. The differential CCRGs...

Source

Identifiers

PMID: 33869220
DOI: 10.3389/fcell.2021.655950

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related GenesPMID 33869220Read ↗

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity Read ↗

A 5-mRNA-Based Prognostic Signature of Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosisSemantic proximity Read ↗

Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinomaSemantic proximity Read ↗

Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinomaSemantic proximity Read ↗

The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformaticsSemantic proximity Read ↗

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)Semantic proximity Read ↗

Identification key genes, key miRNAs and key transcription factors of lung adenocarcinomaSemantic proximity Read ↗

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinomaSemantic proximity Read ↗

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinomaSemantic proximity Read ↗

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional charactersSemantic proximity Read ↗

Identification of T-cell exhaustion-related genes and prediction of their immunotherapeutic role in lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.